Request Information

You are requesting information on:
Ensysce Biosciences And Quotient Sciences Announce A Partnership An The Development And Clinical Testing Of Ensysce's PF614-MPAR A Novel Opioid Designed To Prevent Abuse And Overdose
Quotient Sciences

Already a member of Clinical Leader or VertMarkets? Sign in now.

E-mail

First Name

Last Name

Job Title

Job Function

Company

Phone

Address

City

State

Country

Zip/Postal Code

Save my information

Why?

In order for our suppliers to better serve your request, please enter specific requirements or questions below:

Additional Information

I agree to the Terms.

I agree to the Privacy Statement.

This website uses cookies to ensure you get the best experience on our website. Learn more